GUIDED THERAPEUTICS INC

GTHP

GUIDED THERAPEUTICS INC

GTHP

Insider Sentiment (TTM):

Last Purchase:2025-08-29Last Sale:-Shares Purchased (TTM):346,553Shares Sold (TTM):0

Institutional Sentiment:

As of:2021-06-30Institutional Shares Owned:1Shares Outstanding:13,280Institutional Ownership Pct.:0.01%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Series C Preferred Shares	-	-	-	0	-0	0	0	0	-	0	0	0
Series C One Preferred Shares	-	-	-	0	0	0	0	-	-	0	0	-1
Series C Two Preferred Shares	-	-	-	0	0	0	0	-	-	0	0	0
Series E Convertible Preferred Shares	-	-	-	-0	-0	0	0	0	0	0	0	0
Series F Two Convertible Preferred Shares	-	-	-	0	-0	0	0	-	-	0	0	0
Assets Current
Cash And Cash Equivalents At Carrying Value	0	0	0	0	0	0	0	0	0	0	1	1
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Inventory Net	1	0	0	1	1	1	1	1	1	1	1	1
Other Assets Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	1	1	1	1	1	1	1	1	1	1	1	2
Assets Noncurrent
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	1	1	1	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets Noncurrent	1	1	1	0	0	0	0	0	0	0	0	0
Assets	1	2	1	1	1	1	1	1	1	1	2	2
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	2	2	2	2	2	2	2	2	2	2	2
Accrued Liabilities Current	1	1	2	1	1	1	1	1	1	1	1	1
Deferred Revenue Current	0	0	0	1	1	1	1	1	1	1	0	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Short Term Bank Loans And Notes Payable	-	-	-	-	-	-	-	0	-	-	-	-
Debt Default Shortterm Debt Amount	-	-	-	-	-	-	-	1	1	-	-	-
Derivative Fair Value Of Derivative Liability	-	-	-	-	-	-	-	0	0	-	-	-
Notes Payable Current	0	0	-	-	0	-	-	-	-	-	-	-
Convertible Notes Payable Current	0	0	0	0	0	-	0	-	-	-	-	-
Derivative Liabilities Current	0	0	0	0	0	0	0	-	-	-	0	-
Liabilities Current	6	6	7	6	6	6	6	6	6	5	5	5
Liabilities Noncurrent
Operating Lease Liability Noncurrent	1	1	1	0	0	0	0	0	0	0	0	0
Long Term Notes Payable	0	0	0	0	0	0	0	0	0	-	0	-
Convertible Debt Noncurrent	-	-	0	0	0	0	0	-	-	-	0	0
Derivative Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Short Term Non Bank Loans And Notes Payable	-	-	0	-	-	0	0	-	0	0	0	0
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Noncurrent	1	1	1	0	0	0	0	0	0	0	1	1
Liabilities	7	7	7	7	6	6	6	6	6	6	5	6
Commitments And Contingen…
Stockholders Equity
Common Stock Value	3	3	3	3	3	3	3	3	3	3	3	3
Additional Paid In Capital	149	149	146	145	144	144	143	142	141	141	141	141
Stockholders Equity Before Treasury Stock	-	-	-0	-	-	-	-0	-	-	-	-	-
Treasury Stock Common Value	-0	-0	-	-0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-159	-158	-157	-156	-155	-154	-154	-153	-152	-152	-151	-151
Stockholders Equity	-6	-5	-6	-6	-5	-5	-5	-5	-5	-4	-4	-4
Liabilities And Stockholders Equity	1	2	1	1	1	1	1	1	1	1	2	2
Series D Convertible Preferred Shares	-	-	-	0	-0	0	0	0	0	0	0	0
Series F Convertible Preferred Shares	-	-	-	0	-0	0	0	0	0	0	0	0
Assets
Series C One Convertible Preferred Shares	-	-	-	0	-0	0	0	0	0	0	0	0
Series C Two Convertible Preferred Shares	-	-	-	0	-5	5	0	0	0	0	0	0
Series C Preferred Share	-	-	-	0	-	-	-	-	-	-	-	-
Accounts And Notes Receivable Net	-	-	-	0	0	0	0	0	0	0	0	0
Inventory Finished Goods Net Of Reserves	-	-	-	-	-	1	1	1	1	1	1	1
Allowance For Doubtful Accounts Receivable	0	0	0	-	-	-	0	-	-	-	-	-
Inventory Valuation Reserves	1	1	1	1	1	-	1	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	500	500	500	500	500	500	500	500	500	500	500	500
Common Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	0.00%	40.00%	50.00%	-	-	-	-	-	-	-	-	-
2025	85.56%	195.56%	177.78%	10.24%	-5.91%	6.30%	11.11%	140.00%	121.33%	-13.04%	-21.74%	26.09%
2024	0.00%	46.94%	14.29%	12.71%	52.54%	35.59%	0.59%	-5.88%	-23.53%	9.00%	40.00%	130.00%
2023	-	-	-	-	-	-	7.69%	16.15%	43.08%	-13.79%	-22.41%	20.69%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.09	0.15	0.09	0.12	0.13	0.14	0.19	0.17	0.18	0.23	0.29	0.33
Quick Ratio	0.00	0.07	0.02	0.03	0.03	0.03	0.09	0.07	0.07	0.11	0.16	0.19
Working Capital	-5.64M	-5.05M	-6.03M	-5.67M	-5.57M	-5.09M	-4.96M	-4.98M	-4.71M	-4.10M	-3.42M	-3.26M
Leverage & Debt
Debt to Equity	-1.21	-1.31	-1.22	-1.16	-1.17	-1.19	-1.28	-1.25	-1.27	-1,372.38	-1.44	-1.51
Interest Coverage TTM	-3.29	-3.64	-3.84	-3.87	-4.16	-4.66	-5.53	-6.46	-7.53	-10.77	-12.44	-14.20
Debt Ratio	5.82	4.23	5.54	7.25	6.82	6.20	4.55	4.94	4.73	3.69	3.28	2.94
Efficiency & Turnover
Asset Turnover TTM	0.61	0.60	0.57	0.17	0.11	0.00	0.00	0.02	0.02	0.04	0.04	0.02
Days Sales Outstanding TTM	3.37	1.43	1.67	8.20	15.47	1,642.50	260.71	43.22	43.22	31.16	24.21	38.71
Receivables Turnover TTM	108.33	255.67	219.14	44.50	23.60	0.22	1.40	8.44	8.44	11.71	15.08	9.43
Per Share Metrics
Diluted EPS TTM	-30.89	-36.39	-40.76	-31.67	-32.18	-35.71	-42.15	-43.83	-44.39	-60.84	-73.52	-98.83
Free Cash Flow Per Share TTM	-15.60	-15.26	-13.65	-13.60	-16.55	-19.77	-19.52	-19.69	-19.96	-24.22	-32.27	-34.04
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	-	32.93%	36.73%	-89.39%
Operating Profit Margin TTM	-303.85%	-294.65%	-309.26%	-1,233.15%	-1,924.58%	-216,300.00%	-30,114.29%	-5,423.68%	-5,586.84%	-3,625.61%	-3,527.55%	-5,939.39%
Net Profit Margin TTM	-458.77%	-421.51%	-416.69%	-1,453.37%	-2,150.00%	-243,900.00%	-34,528.57%	-6,578.95%	-6,539.47%	-4,062.20%	-3,835.71%	-7,707.58%
Growth Metrics
Net Revenue Growth (1Y)	450.85%	76,600.00%	10,857.14%	368.42%	210.53%	-98.78%	-92.86%	-42.42%	-44.93%	173.33%	653.85%	-9.59%
Net Income Growth (1Y)	17.54%	32.55%	32.23%	3.48%	2.09%	-26.78%	-35.70%	-50.86%	-54.52%	-30.40%	-24.40%	30.54%
EPS Growth (1Y)	-4.01%	1.90%	-3.31%	-27.75%	-27.14%	-40.37%	-39.33%	-55.65%	-58.77%	-36.41%	-54.58%	69,850.91%
Valuation Metrics
P/E TTM	-0.01	-0.01	-0.01	-0.01	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
P/B TTM	-0.00	-0.00	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-1.61	-0.00	-0.00
P/S TTM	0.04	0.03	0.06	0.11	0.17	6.83	1.23	0.26	0.18	0.08	0.09	0.13
Market Cap	23.17K	20.43K	42.34K	19.61K	19.71K	6.83K	8.60K	9.98K	6.75K	6.45K	8.33K	8.49K
Enterprise Value	354.17K	-2.57K	349.34K	372.61K	314.71K	-32.17K	-201.40K	-131.02K	-209.25K	-438.55K	-582.67K	-722.51K
Calculated Values
Free Cash Flow TTM	-1.51M	-1.36M	-1.07M	-1.11M	-1.31M	-1.35M	-1.12M	-1.12M	-1.12M	-1.35M	-1.75M	-1.75M
Net Debt	331.00K	-23.00K	307.00K	353.00K	295.00K	-39.00K	-210.00K	-141.00K	-216.00K	-445.00K	-591.00K	-731.00K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-08-29Purchase

Owner: James, Michael C

Title: -

Shares: 27,778

Price/Share: $0.18

Value: $5,000.04

Shares Owned: 553,495

Relationship: Director

Ownership: Direct

2025-08-29Purchase

Owner: Imhoff, John E

Title: -

Shares: 166,667

Price/Share: $0.18

Value: $30,000.06

Shares Owned: 19,463,495

Relationship: Director,TenPercentOwner

Ownership: Direct

2025-08-29Purchase

Owner: Grujic, Alan

Title: -

Shares: 152,108

Price/Share: -

Value: -

Shares Owned: 1,817,541

Relationship: Director

Ownership: Direct

2025-03-18Purchase

Owner: Imhoff, John E

Title: -

Shares: 1,263,069

Price/Share: $0.10

Value: $126,306.90

Shares Owned: 17,986,015

Relationship: Director,TenPercentOwner

Ownership: Direct

2025-03-18Purchase

Owner: James, Michael C

Title: -

Shares: 412,945

Price/Share: $0.10

Value: $41,294.50

Shares Owned: 525,717

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-08-29	James, Michael C	Director	-	Direct	Purchase	27,778	0.18	$5,000.04	553,495	4
2025-08-29	Imhoff, John E	Director,TenPercentOwner	-	Direct	Purchase	166,667	0.18	$30,000.06	19,463,495	4
2025-08-29	Grujic, Alan	Director	-	Direct	Purchase	152,108	-	-	1,817,541	4
2025-03-18	Imhoff, John E	Director,TenPercentOwner	-	Direct	Purchase	1,263,069	0.10	$126,306.90	17,986,015	4/A
2025-03-18	James, Michael C	Director	-	Direct	Purchase	412,945	0.10	$41,294.50	525,717	4
2024-12-18	Imhoff, John E	Director,TenPercentOwner	-	Direct	Purchase	1,615,385	-	-	8,727,444	4
2024-09-23	Imhoff, John E	Director,TenPercentOwner	-	Direct	Purchase	1,666,667	-	-	7,075,898	4
2023-08-11	Imhoff, John E	Director,TenPercentOwner	-	Direct	Purchase	500,899	-	-	4,937,536	4
2022-09-02	Blumberg, Richard P.	Director,TenPercentOwner	-	Direct	Purchase	1,000,000	-	-	2,109,715	4
2022-09-02	James, Michael C	Director,TenPercentOwner	-	Direct	Purchase	100,000	-	-	112,772	4
2022-09-02	Imhoff, John E	Director,TenPercentOwner	-	Direct	Purchase	500,000	-	-	4,356,532	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2021-06-30

0.01%

Inst. Shares: 1

Shares Outstanding: 13,280

2021-03-31

0.02%

Inst. Shares: 2

Shares Outstanding: 13,172

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2021-06-30	1	13,280	0.01%
2021-03-31	2	13,172	0.02%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

GUIDED THERAPEUTICS INC (GTHP) — SEC Financial Statements & Analysis

GUIDED THERAPEUTICS INC (GTHP) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. GUIDED THERAPEUTICS INC trades on OTC as: GTHP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), GUIDED THERAPEUTICS INC reported a 450.85% year-over-year revenue growth, a Gross Profit Margin of 32.93% (TTM), a Debt-to-Equity ratio of -1.21x, a Price-to-Sales (P/S) ratio of 0.04x (TTM), a Price-to-Book (P/B) ratio of -0.00x (TTM), at a market cap of $23.17K. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 450.85%
Gross Profit Margin TTM: 32.93%
Debt To Equity: -1.21x
P/S TTM: 0.04x
P/B TTM: -0.00x
Market Cap: $23.17K

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is GUIDED THERAPEUTICS INC in?

GUIDED THERAPEUTICS INC (GTHP) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is GTHP's market cap?

GUIDED THERAPEUTICS INC (GTHP) has a market capitalization of $23.17K as of 2026-06-30.

What exchange does GTHP trade on?

GUIDED THERAPEUTICS INC (GTHP) trades on the OTC.

Where is GUIDED THERAPEUTICS INC incorporated?

GUIDED THERAPEUTICS INC is incorporated in DE.